Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has ...
The Trump administration directed federal health officials to pause external communications last week, which prompted the ...